Bilirubin Production and the Risk of Bilirubin Neurotoxicity

Seminars in Perinatology

Volumn 35, Issue 3, 2011, Pages 121-126

  Stevenson, David K ^a   Vreman, Hendrik J ^a   Wong, Ronald J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BIND; Heme oxygenase; Hyperbilirubinemia; Jaundice

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; FERROUS ION; HEME OXYGENASE; HEME OXYGENASE 1;

BILIRUBIN BINDING; BILIRUBIN BLOOD LEVEL; BILIRUBIN METABOLISM; DISEASE ASSOCIATION; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; KERNICTERUS; NEUROTOXICITY; NEWBORN JAUNDICE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

BILIRUBIN; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS;

EID: 79957947773     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2011.02.005     Document Type: Review

References (71)

1. Bhutani V.K., Johnson L., Sivieri E.M. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999, 103:6-14.
2. Maisels M.J. Jaundice. Neonatology: Pathophysiology and Management of the Newborn 1999, 765-819. Lippincott Williams and Wilkins, Philadelphia. G.B. Avery, M.A. Fletcher, M.G. MacDonald (Eds.).
3. Thaler M.M., Gellis S.S. Studies in neonatal hepatitis and biliary atresia. 3. Progression and regression of cirrhosis in biliary atresia. Am J Dis Child 1968, 116:271-279.
4. Kramer L.I. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child 1969, 118:454-458.
5. Knudsen A. The cephalocaudal progression of jaundice in newborns in relation to the transfer of bilirubin from plasma to skin. Early Hum Dev 1990, 22:23-28.
6. Cohen R.S., Wong R.J., Stevenson D.K. Understanding neonatal jaundice: A perspective on causation. Pediatr. J Neonatol 2010, 51:143-148.
7. Kaplan M., Muraca M., Hammerman C., et al. Imbalance between production and conjugation of bilirubin: A fundamental concept in the mechanism of neonatal jaundice. Pediatrics 2002, 110:e47.
8. Stevenson D.K., Dennery P.A., Hintz S.R. Understanding newborn jaundice. J Perinatol 2001, 21(suppl 1):S21-S24. discussion: S35-S29.
9. Sorrentino D., Stremmel W., Berk P.D. The hepatocellular uptake of bilirubin: Current concepts and controversies. Mol Aspects Med 1987, 9:405-428.
10. Akaba K., Kimura T., Sasaki A., et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: A common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int 1998, 46:21-26.
11. Yamamoto K., Sato H., Fujiyama Y., et al. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta 1998, 1406:267-273.
12. Gartner L.M., Auerbach K.G. Breast milk and breastfeeding jaundice. Adv Pediatr 1987, 34:249-274.
13. Gourley G.R. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol 2002, 7:135-141.
14. Gartner L.M. Neonatal jaundice. Pediatr Rev 1994, 15:422-432.
15. Vreman H.J., Rodgers P.A., Gale R., et al. Carbon monoxide excretion as an index of bilirubin production in rhesus monkeys. J Med Primatol 1989, 18:449-460.
16. Stevenson D.K., Vreman H.J., Oh W., et al. Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clin Chem 1994, 40:1934-1939.
17. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 1968, 61:748-755.
18. Watts R.N., Ponka P., Richardson D.R. Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: Mirror-image effector molecules that target iron. Biochem J 2003, 369:429-440.
19. Vreman H.J., Wong R.J., Sanesi C.A., et al. Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system. Can J Physiol Pharmacol 1998, 76:1057-1065.
20. Vreman H.J., Gillman M.J., Downum K.R., et al. In vitro generation of carbon monoxide from organic molecules and synthetic metalloporphyrins mediated by light. Dev Pharmacol Ther 1990, 15:112-124.
21. Stevenson D.K., Bartoletti A.L., Ostrander C.R., et al. Pulmonary excretion of carbon monoxide in the human infant as an index of bilirubin production. IV. Effects of breast-feeding and caloric intake in the first postnatal week. Pediatrics 1980, 65:1170-1172.
22. Vreman H.J., Mahoney J.J., Stevenson D.K. Carbon monoxide and carboxyhemoglobin. Adv Pediatr 1995, 42:303-334.
23. Stevenson D.K., Wong R.J., DeSandre G.H., et al. A primer on neonatal jaundice. Adv Pediatr 2004, 51:263-288.
24. Smith D.W., Hopper A.O., Shahin S.M., et al. Neonatal bilirubin production estimated from "end-tidal" carbon monoxide concentration. J Pediatr Gastroenterol Nutr 1984, 3:77-80.
25. Vreman H.J., Baxter L.M., Stone R.T., et al. Evaluation of a fully automated end-tidal carbon monoxide instrument for breath analysis. Clin Chem 1996, 42:50-56.
26. Vreman H.J., Stevenson D.K., Oh W., et al. Semiportable electrochemical instrument for determining carbon monoxide in breath. Clin Chem 1994, 40:1927-1933.
27. Vreman H.J., Wong R.J., Harmatz P., et al. Validation of the Natus CO-Stat End Tidal Breath Analyzer in children and adults. J Clin Monit Comput 1999, 15:421-427.
28. Maines M.D. Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988, 2:2557-2568.
29. Maines M.D. Heme Oxygenase: Clinical Applications and Functions 1992, 276. CRC Press, Boca Raton, FL.
30. Maines M.D. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997, 37:517-554.
31. Maines M.D. Zinc•protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim Biophys Acta 1981, 673:339-350.
32. Stevenson D.K., Rodgers P.A., Vreman H.J. The use of metalloporphyrins for the chemoprevention of neonatal jaundice. Am J Dis Child 1989, 143:353-356.
33. Morioka I., Wong R.J., Abate A., et al. Systemic effects of orally-administered zinc and tin (IV) metalloporphyrins on heme oxygenase expression in mice. Pediatr Res 2006, 59:667-672.
34. Vreman H.J., Cipkala D.A., Stevenson D.K. Characterization of porphyrin heme oxygenase inhibitors. Can J Physiol Pharmacol 1996, 74:278-285.
35. Vreman H.J., Ekstrand B.C., Stevenson D.K. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res 1993, 33:195-200.
36. Vreman H.J., Rodgers P.A., Stevenson D.K. Zinc protoporphyrin administration for suppression of increased bilirubin production by iatrogenic hemolysis in rhesus neonates. J Pediatr 1990, 117:292-297.
37. Vreman H.J., Wong R.J., Stevenson D.K. Alternative metalloporphyrins for the treatment of neonatal jaundice. J Perinatol 2001, 21(suppl 1):S108-S113.
38. Wong R.J., Bhutani V.K., Vreman H.J., et al. Tin mesoporphyrin for the treatment of neonatal hyperbilirubinemia. Neorev 2007, 8:e77-e84.
39. Shibahara S., Kitamuro T., Takahashi K. Heme degradation and human disease: Diversity is the soul of life. Antioxid Redox Signal 2002, 4:593-602.
40. Exner M., Minar E., Wagner O., et al. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004, 37:1097-1104.
41. Denschlag D., Marculescu R., Unfried G., et al. The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol Hum Reprod 2004, 10:211-214.
42. Bainbridge S.A., Smith G.N. HO in pregnancy. Free Radic Biol Med 2005, 38:979-988.
43. Cudmore M., Ahmad S., Al-Ani B., et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007, 115:1789-1797.
44. Yamada N., Yamaya M., Okinaga S., et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000, 66:187-195.
45. Schillinger M., Exner M., Mlekusch W., et al. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res 2002, 106:131-136.
46. Endler G., Exner M., Schillinger M., et al. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost 2004, 91:155-161.
47. Funk M., Endler G., Schillinger M., et al. The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: The influence of other vascular risk factors. Thromb Res 2004, 113:217-223.
48. Vreman H.J., Wong R.J., Stevenson D.K. Carbon monoxide in breath, blood, and other tissues, in Penney DG (ed): Carbon Monoxide Toxicity 2000, 19-60. CRC Press, Boca Raton, FL.
49. Kaplan M., Vreman H.J., Hammerman C., et al. Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: Effect on hemolysis and neonatal hyperbilirubinemia. Acta Paediatr 1998, 87:455-457.
50. Kaplan M., Hammerman C., Vreman H.J., et al. Hemolysis and hyperbilirubinemia in direct antiglobulin titer positive, ABO blood group heterospecific neonates. J Pediatr 2010, 157:772-777.
51. Galanello R., Cipollina M.D., Carboni G., et al. Hyperbilirubinemia, glucose-6-phosphate-dehydrogenase deficiency and Gilbert's syndrome. Eur J Pediatr 1999, 158:914-916.
52. Kaplan M., Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: A hidden risk for kernicterus. Semin Perinatol 2004, 28:356-364.
53. Bhutani V.K., Johnson L. Synopsis report from the pilot USA Kernicterus Registry. J Perinatol 2009, 29(suppl 1):S4-S7.
54. Johnson L., Bhutani V.K., Karp K., et al. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 2009, 29(suppl 1):S25-S45.
55. Maruo Y., Nishizawa K., Sato H., et al. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 1999, 103:1224-1227.
56. Stevenson D.K., Bartoletti A.L., Ostrander C.R., et al. Pulmonary excretion of carbon monoxide in the human newborn infant as an index of bilirubin production: III. Measurement of pulmonary excretion of carbon monoxide after the first postnatal week in premature infants. Pediatrics 1979, 64:598-600.
57. Morris B.H., Oh W., Tyson J.E., et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 2008, 359:1885-1896.
58. Vreman H.J., Knauer Y., Wong R.J., et al. Dermal carbon monoxide excretion in neonatal rats during light exposure. Pediatr Res 2009, 66:66-69.
59. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of hemoglobin to bilirubin. Trans Assoc Am Physicians 1969, 82:363-371.
60. Management of hyperbilirubinemia in the newborn infant ≤35 weeks of gestation. Pediatrics 2004, 114:297-316. American Academy of Pediatrics.
61. Hsia D.Y.Y., Allen F.H.J., Diamond L.K. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to Kernicterus. N Engl J Med 1952, 247:668-671.
62. Newman T.B., Maisels M.J. Does hyperbilirubinemia damage the brain of healthy full-term infants?. Clin Perinatol 1990, 17:331-358.
63. Watchko J.F., Oski F.A. Bilirubin 20 mg/dL = vigintiphobia. Pediatrics 1983, 71:660-663.
64. Perlman J.M., Rogers B.B., Burns D. Kernicteric findings at autopsy in two sick near term infants. Pediatrics 1997, 99:612-615.
65. Govaert P., Lequin M., Swarte R., et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics 2003, 112:1256-1263.
66. Hansen TW, Bratlid D: Bilirubin and brain toxicity. Acta Paediatr Scand 75:513-522,.
67. Chuniaud L., Dessante M., Chantoux F., et al. Cytotoxicity of bilirubin for human fibroblasts and rat astrocytes in culture. Effect of the ratio of bilirubin to serum albumin. Clin Chim Acta 1996, 256:103-114.
68. Brites D., Fernandes A., Falcao A.S., et al. Biological risks for neurological abnormalities associated with hyperbilirubinemia. J Perinatol 2009, 29(suppl 1):S8-S13.
69. Ahlfors C.E. Unbound bilirubin associated with kernicterus: A historical approach. J Pediatr 2000, 137:540-544.
70. Wennberg R.P., Ahlfors C.E., Bhutani V.K., et al. Toward understanding kernicterus: A challenge to improve the management of jaundiced newborns. Pediatrics 2006, 117:474-485.
71. Oh W., Stevenson D.K., Tyson J.E., et al. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr 2010, 99:673-678.